CLINICAL_TRIALS trial_result · 2022-10-10

Clinical Trial Update: A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug) in the Treatment of Diabetic Macular Edema. [Phase 2]

Phase 2 trial evaluating oral danazol for diabetic macular edema completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Ampio Pharmaceuticals. Inc. | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2022-10-10